[144] Xylem Inc SEC Filing

Rhea-AI Filing Summary

Xylem Inc. (XYL) Form 144 notifies a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $139,962. The filing lists the issuer's outstanding common shares as 243,409,688, and shows an approximate sale date of 09/05/2025. The shares reported were acquired primarily via the company's Employee Stock Purchase Plan in multiple small purchases between 03/23/2023 and 03/01/2024, with the largest single acquisition entries totaling 477, 322, and 136 shares.

The notice contains no reportable sales in the past three months and includes the standard representation that the seller is unaware of undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for a small block of shares acquired through ESPP; likely immaterial to XYL's valuation.

This Form 144 reports a proposed sale of 1,000 common shares valued at about $140k against ~243.4 million outstanding shares, representing an immaterial dilution and ownership change. The holdings were accumulated through an Employee Stock Purchase Plan in small tranches, indicating personal liquidity rather than strategic disposition. No recent sales in the prior three months are reported, and there is a standard certification regarding material nonpublic information. Overall, this is a routine disclosure with limited investor impact.

Corporate Governance Specialist

TL;DR: Compliance filing shows planned broker-assisted sale; governance and disclosure procedures appear followed.

The notice identifies Morgan Stanley Smith Barney as the executing broker and provides required acquisition history for the securities to be sold, demonstrating compliance with Rule 144 aggregation and disclosure rules. The seller affirms no undisclosed material adverse information and the form contains the customary legal notice about intentional misstatements. There are no indications of coordination with other significant holders or unusual transaction structures in the provided data.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1000	139962.00	243409688	09/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2024	Shares Purchased through Employee Stock Purchase Plan	Issuer			136	03/01/2024	Services Rendered
Common	12/20/2023	Shares Purchased through Employee Stock Purchase Plan	Issuer			7	12/20/2023	Services Rendered
Common	03/23/2023	Shares Purchased through Employee Stock Purchase Plan	Issuer			4	03/23/2023	Services Rendered
Common	03/01/2024	Shares Purchased through Employee Stock Purchase Plan	Issuer			322	03/01/2024	Services Rendered
Common	03/01/2023	Shares Purchased through Employee Stock Purchase Plan	Issuer			31	03/01/2023	Services Rendered
Common	06/29/2023	Shares Purchased through Employee Stock Purchase Plan	Issuer			7	06/29/2023	Services Rendered
Common	03/01/2024	Shares Purchased through Employee Stock Purchase Plan	Issuer			477	03/01/2024	Services Rendered
Common	06/28/2024	Shares Purchased through Employee Stock Purchase Plan	Issuer			7	06/28/2024	Services Rendered
Common	09/29/2023	Shares Purchased through Employee Stock Purchase Plan	Issuer			9	09/29/2023	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Xylem Inc. (XYL) disclose?

The form discloses a proposed sale of 1,000 common shares via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $139,962 and an approximate sale date of 09/05/2025.

How many Xylem (XYL) shares are outstanding according to the filing?

The filing reports 243,409,688 shares outstanding.

How were the shares being sold acquired?

The shares were acquired through the issuer's Employee Stock Purchase Plan (ESPP) in multiple small purchases between 03/23/2023 and 03/01/2024.

Were there any Xylem (XYL) sales by this person in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Which broker will execute the proposed sale of XYL shares?

The designated broker is Morgan Stanley Smith Barney LLC, address listed in the notice.